Aug 10, 2026 08:03AM
Aug 10, 2026 08:00AM
Jun 15, 2026 08:01AM
Jun 15, 2026 08:00AM
May 20, 2026 08:00AM
Apr 30, 2026 08:50AM
Apr 30, 2026 08:00AM Telomir Pharmaceuticals Announces FDA Clearance of IND for Telomir-Zn in Triple-Negative Breast Cancer
Apr 24, 2026 09:00AM
Apr 24, 2026 09:00AM
Mar 31, 2026 08:06AM
Mar 31, 2026 08:00AM
Nov 25, 2025 08:02AM
Nov 25, 2025 08:00AM
Nov 21, 2025 07:30AM Telomir reports drug candidate shows activity against leukemia cells
Nov 21, 2025 07:30AM
Nov 12, 2025 08:01AM
Nov 12, 2025 08:00AM
Jun 18, 2025 09:15AM
Jun 18, 2025 09:15AM
Jun 11, 2025 09:42AM
Jun 11, 2025 09:30AM Telomir Pharmaceuticals Announces Telomir-1 Demonstrates Dose-Dependent Restoration of Neurological, Liver and Kidney Functions in Preclinical Wilson's Disease Model
Jun 5, 2025 08:30AM
Jun 2, 2025 08:30AM
May 29, 2025 08:43AM
May 29, 2025 08:30AM
May 21, 2025 09:03AM
May 21, 2025 09:00AM
May 7, 2025 08:04AM Telomir Pharmaceuticals (TELO) Demonstrates Telomir-1 Reverses Key Drivers of Cellular Decline in Human Cell Lines Supporting Therapeutic Potential in Autism and Spasmodic Dysphonia
May 7, 2025 08:00AM
Mar 19, 2025 08:03AM
Mar 19, 2025 08:00AM
Feb 26, 2025 08:04AM
Feb 26, 2025 08:00AM
Feb 21, 2025 08:02AM
Feb 21, 2025 08:00AM Telomir Pharmaceuticals Achieves Breakthrough in Silver Ion Stabilization, Unlocking a Multi-Billion-Dollar Medical Market
Feb 18, 2025 08:02AM
Feb 18, 2025 08:00AM
Jan 28, 2025 08:02AM
Jan 28, 2025 08:00AM
Jan 7, 2025 08:02AM
Jan 7, 2025 08:00AM
Dec 23, 2024 07:32AM Telomir Pharmaceuticals (TELO) Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease
Dec 23, 2024 07:30AM
Dec 12, 2024 08:33AM
Dec 12, 2024 08:30AM
Dec 3, 2024 07:32AM
Dec 3, 2024 07:30AM
Nov 21, 2024 07:04AM
Nov 21, 2024 07:00AM Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Sep 26, 2024 04:00PM

329,928 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All